Answer
Aug 14, 2025 - 12:12 PM
Retatrutide is an investigational medication, and as of my last update, specific dosing recommendations have not been finalized or approved by regulatory authorities. Typically, such information would be provided by healthcare professionals or detailed in the prescribing information once the medication is approved. It's crucial to follow the guidance of a healthcare provider for any off-label or investigational use.
